CHARACTERISTICS OF RE-BIOPSIED NSCLC PATIENTS WITH ACQUIRED RESISTANCE TO EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS

被引:0
|
作者
Arai, Daisuke [1 ]
Soejima, Kenzo [1 ]
Yasuda, Hiroyuki [1 ]
Tani, Tetsuo [1 ]
Kuroda, Aoi [1 ]
Ishioka, Kota [1 ]
Ohgino, Keiko [1 ]
Sato, Takashi [1 ]
Terai, Hideki [1 ]
Ikemura, Shinnosuke [1 ]
Hamamoto, Junko [1 ]
Naoki, Katsuhiko [1 ]
Hayashi, Yuichiro [2 ]
Betsuyaku, Tomoko [1 ]
机构
[1] Keio Univ, Dept Med, Div Pulm Med, Sch Med, Tokyo 108, Japan
[2] Keio Univ, Dept Pathol, Sch Med, Tokyo 108, Japan
关键词
EGFR mutation; aquired resistance; re-biopsy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.10-039
引用
收藏
页码:S581 / S582
页数:2
相关论文
共 50 条
  • [21] Pharmacogenomics of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
    Jimeno, Antonio
    Hidalgo, Manuel
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2006, 1766 (02): : 217 - 229
  • [22] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Depression Reply
    Morgan, Jeffrey A.
    Quek, Richard
    George, Suzanne
    Block, Susan D.
    Demetri, George D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (23) : E51 - E51
  • [23] Pharmacophore analysis of epidermal growth factor receptor tyrosine kinase inhibitors
    Peng, T
    Pei, JF
    Zhou, JJ
    ACTA CHIMICA SINICA, 2003, 61 (03) : 430 - 434
  • [24] Evaluation of Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
    James M. Rae
    Marc E. Lippman
    Breast Cancer Research and Treatment, 2004, 83 : 99 - 107
  • [25] Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor
    Liechti, C
    Séquin, U
    Bold, G
    Furet, P
    Meyer, T
    Traxler, P
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2004, 39 (01) : 11 - 26
  • [26] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Anticancer Agents
    Fortunato Ciardiello
    Drugs, 2000, 60 : 25 - 32
  • [27] Epidermal growth factor receptor tyrosine kinase inhibitors: similar but different?
    Rukazenkov, Yuri
    Speake, Georgina
    Marshall, Gayle
    Anderton, Judith
    Davies, Barry R.
    Wilkinson, Robert W.
    Hickinson, D. Mark
    Swaisland, Alan
    ANTI-CANCER DRUGS, 2009, 20 (10) : 856 - 866
  • [28] Evolving Landscape of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
    Kao, Steven C.
    Boyer, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (27) : 3233 - 3234
  • [29] Evaluation of novel epidermal growth factor receptor tyrosine kinase inhibitors
    Rae, JM
    Lippman, ME
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 83 (02) : 99 - 107
  • [30] Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents
    Ciardiello, F
    DRUGS, 2000, 60 (Suppl 1) : 25 - 32